Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)
Brazil flag Brazil · Delayed Price · Currency is BRL
67.75
-0.15 (-0.22%)
At close: Feb 6, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Net Product Sales Revenue
6.31B7.63B
Net Product Sales Revenue Growth
-17.30%7.79%
Total Collaboration Revenue
7.33B6.06B
Total Collaboration Revenue Growth
21.02%10.08%
Other Product Revenue
702.60M515.00M
Other Product Revenue Growth
36.43%-3.94%
Revenue (Total)
14.34B14.20B
Revenue (Total) Growth
0.99%8.27%
Updated Dec 31, 2025. Data Source: Fiscal.ai.